Fact CheckerSign in

NCT05300672CompletedPhase 3

Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis (FibER)

Fibrinogen Replacement to Prevent Intracranial Haemorrhage in Ischemic Stroke Patients After Thrombolysis: a Pilot Probe Randomized Controlled Trial (FibER)

Source: ClinicalTrials.gov · Last updated 1 Aug 2025

Brief summary (registry, in English)

Fibrinogen replacement could prevent haemorrhagic complications in ischemic stroke patients with secondary post-rtPA hypofibrinogenemia

Status (registry)
Completed
Phase (registry)
Phase 3
Study type
Interventional
Enrollment
207 (actual)
First submitted
1 Mar 2022
Start date
8 Feb 2022
Primary completion date
31 Dec 2024
Lead sponsor
Azienda Usl di Bologna
Diseases
Stroke
NCT number
NCT05300672
EU CT number
2024-516731-27-00
EudraCT number
2020-005242-41

What you commit to

  • Study type: Interventional · Phase 3
  • Participants enrolled: 207
  • From 8 Feb 2022 to the primary completion date, 31 Dec 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • contraindication to rtPA treatment;
  • patients who present symptomatic ICH during infusion of rt-PA,
  • absence of written informed consent

Who the study is looking for

  • patients with acute ischemic stroke treated with i.v. thrombolysis (rtPA 0,9 mg/Kg, 10% in bolus and 90% in infusion in 60 minutes)
  • age \>18 years
  • critical hypofibrinogenemia post-tPA, defined as a decrease of serum fibrinogen level \<200 mg/dl and/or a rate decrease \>50% than baseline level
  • written informed consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Azienda Unita Sanitaria Locale Di Bologna
Coordinator of this site? Confirm its status
BolognaItalyNot yet recruiting
Azienda Ospedaliero - Universitaria di Modena
Coordinator of this site? Confirm its status
ModenaItalyNot yet recruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.